Hyo Jung Kim Selected Research

Neoplasms (Cancer)

12/2023	Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.
11/2023	The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC.
10/2023	SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer.
9/2023	Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study.
8/2023	CD74 Promotes a Pro-Inflammatory Tumor Microenvironment by Inducing S100A8 and S100A9 Secretion in Pancreatic Cancer.
1/2023	Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170).
1/2023	Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study.
1/2022	Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction.
8/2021	Anti‑angiogenic effect of mountain ginseng in vitro and in vivo: Comparison with farm‑cultivated ginseng.
1/2021	Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyo Jung Kim Research Topics

Disease

46	Neoplasms (Cancer) 12/2023 - 06/2003
17	Multiple Myeloma 10/2023 - 08/2008
15	Lymphoma (Lymphomas) 10/2023 - 06/2003
12	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 10/2013
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 02/2011
6	Cholangiocarcinoma 01/2023 - 01/2005
6	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 09/2022 - 04/2010
6	Inflammation (Inflammations) 03/2021 - 01/2004
5	Neoplasm Metastasis (Metastasis) 01/2024 - 06/2002
5	Disease Progression 04/2023 - 03/2009
5	Infections 03/2023 - 12/2004
5	Body Weight (Weight, Body) 01/2023 - 06/2011
5	Neutropenia 01/2023 - 04/2010
5	Hepatocellular Carcinoma (Hepatoma) 05/2013 - 10/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2010 - 10/2006
4	Breast Neoplasms (Breast Cancer) 09/2023 - 01/2020
4	Fibrosis (Cirrhosis) 08/2022 - 06/2007
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 06/2006
4	Melanoma (Melanoma, Malignant) 07/2015 - 03/2008
3	Carcinogenesis 12/2023 - 01/2020
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2023 - 01/2020
3	Hepatitis 10/2023 - 01/2011
3	Febrile Neutropenia 01/2023 - 01/2019
3	Thrombocytopenia (Thrombopenia) 01/2023 - 05/2015
3	Fatigue 01/2023 - 03/2015
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2022 - 05/2015
3	Drug-Related Side Effects and Adverse Reactions 01/2022 - 04/2009
3	Gallstones (Gallstone) 01/2017 - 10/2003
3	Vomiting 01/2016 - 09/2013
3	Nausea 01/2016 - 09/2013
3	Hypoxia (Hypoxemia) 01/2016 - 09/2007
3	Obesity 01/2016 - 06/2011
3	Pain (Aches) 01/2016 - 06/2002
3	Stomach Neoplasms (Stomach Cancer) 10/2009 - 02/2009
2	Adenocarcinoma 01/2024 - 02/2017
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2023 - 11/2012
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 04/2013
2	Dizziness (Lightheadedness) 10/2021 - 08/2012
2	Tuberculosis (Tuberculoses) 09/2021 - 07/2020
2	Weight Loss (Weight Reduction) 04/2021 - 08/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2021 - 05/2007
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 04/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 06/2020
2	Cancer Pain 01/2021 - 04/2013

Drug/Important Bio-Agent (IBA)

12	Rituximab (Mabthera)FDA Link 10/2023 - 11/2010
12	Proteins (Proteins, Gene)FDA Link 07/2020 - 06/2007
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 11/2012
10	Dexamethasone (Maxidex)FDA LinkGeneric 04/2021 - 05/2010
9	Gemcitabine FDA Link 12/2023 - 10/2006
8	Vincristine (Oncovin)FDA LinkGeneric 10/2023 - 11/2012
8	Prednisone (Sone)FDA LinkGeneric 01/2023 - 11/2012
8	AntioxidantsIBA 01/2022 - 06/2004
8	Bortezomib (Velcade)FDA Link 01/2021 - 08/2008
7	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 11/2012
6	Prednisolone (Predate)FDA LinkGeneric 10/2023 - 05/2010
6	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2014
6	Cisplatin (Platino)FDA LinkGeneric 02/2016 - 10/2006
5	R-CHOP protocolIBA 01/2023 - 04/2015
5	SteroidsIBA 01/2020 - 01/2011
4	CytokinesIBA 08/2023 - 10/2019
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2023 - 10/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2011
4	CollagenIBA 08/2022 - 06/2010
4	Lenalidomide (CC 5013)FDA Link 01/2021 - 03/2015
4	Thalidomide (Thalomid)FDA Link 01/2021 - 05/2010
4	EnzymesIBA 06/2020 - 06/2004
4	Monophenol Monooxygenase (Tyrosinase)IBA 07/2015 - 03/2008
4	PhytoalexinsIBA 05/2013 - 02/2010
4	ErbB Receptors (EGF Receptor)IBA 04/2009 - 10/2003
3	CateninsIBA 12/2023 - 04/2013
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 02/2012
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 01/2019
3	Inosine Triphosphate (ITP)IBA 07/2022 - 05/2015
3	Indicators and Reagents (Reagents)IBA 04/2022 - 01/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2010
3	Therapeutic UsesIBA 04/2020 - 11/2003
3	GlucocorticoidsIBA 01/2020 - 12/2013
3	Small Interfering RNA (siRNA)IBA 01/2020 - 04/2013
3	Melphalan (Alkeran)FDA LinkGeneric 06/2017 - 05/2010
3	LigandsIBA 01/2016 - 07/2009
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 05/2007
3	Docetaxel (Taxotere)FDA Link 10/2010 - 02/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2010 - 10/2008
3	PPAR gammaIBA 12/2009 - 10/2006
2	Glutathione (Reduced Glutathione)IBA 10/2023 - 05/2013
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2023 - 01/2023
2	pegfilgrastim (Neulasta)FDA Link 01/2023 - 10/2022
2	CreatinineIBA 11/2022 - 04/2018
2	CalciumIBA 11/2022 - 11/2016
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 03/2020
2	MyostatinIBA 04/2021 - 01/2019
2	LipidsIBA 01/2020 - 06/2011

Therapy/Procedure

32	Drug Therapy (Chemotherapy) 11/2023 - 06/2006
21	Therapeutics 12/2023 - 07/2005
7	Radiotherapy 09/2022 - 01/2016
7	Combination Drug Therapy (Combination Chemotherapy) 09/2017 - 02/2009
6	Stem Cell Transplantation 04/2023 - 10/2005
4	Aftercare (After-Treatment) 09/2023 - 06/2015
4	Induction Chemotherapy 01/2022 - 06/2006
3	Transplantation 01/2023 - 06/2017